10.07.2025 • NewsArkemainvestmentpolyamide

Arkema Invests in New Polyamide Unit in Singapore

Arkema recently increased its global Rilsan polyamide 11 production by 50% after opening a new plant in Singapore. The company is now building another unit at the same site to produce Rilsan Clear, a transparent polyamide. This new project will cost about $20 million and is expected to start operating in early 2026.

This investment will increase Arkema’s global production capacity of Rilsan Clear transparent polyamides by three times. The additional capacity is intended to address rising demand for high-performance transparent materials in markets such as eyewear, consumer electronics, healthcare devices, and home appliances.

Arkema produces bio-based transparent polyamides, including Rilsan Clear Rnew G850 and G820, which contain 45% and 62% bio-based carbon, respectively. These materials are designed to be lightweight, transparent, flexible, and resistant to chemicals and temperature changes, and can be recycled through Arkema’s Virtucycle program.

“We are very proud to take this new step forward with this expansion dedicated to transparent polyamides as it aligns with the evolving demand landscape, showcasing our commitment to global growth” said Laurent Tellier, Senior Vice-President High Performance Polymers and Fluorogases. “It marks the next step in developing our strategic platform in Singapore to support our valued customers in Asia and beyond.” 

The project will also contribute to Arkema’s strategy to develop local supply from the region to the region, providing customers with shorter lead times, resilient and competitive local supply chains.

Company

Logo:

Arkema

420 rue d’Estienne d’Orves
92705 Colombes Cedex
France

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.